These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24423630)

  • 1. Mucopolysaccharidoses type I and II: new neuroimaging findings in the cerebellum.
    Alqahtani E; Huisman TA; Boltshauser E; Scheer I; Güngör T; Tekes A; Maegawa GH; Poretti A
    Eur J Paediatr Neurol; 2014 Mar; 18(2):211-7. PubMed ID: 24423630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment reduces or stabilizes brain imaging abnormalities in patients with MPS I and II.
    Wang RY; Cambray-Forker EJ; Ohanian K; Karlin DS; Covault KK; Schwartz PH; Abdenur JE
    Mol Genet Metab; 2009 Dec; 98(4):406-11. PubMed ID: 19748810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation.
    Matheus MG; Castillo M; Smith JK; Armao D; Towle D; Muenzer J
    Neuroradiology; 2004 Aug; 46(8):666-72. PubMed ID: 15205860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of CSF flow using phase-contrast MRI with ventriculomegaly and CSF opening pressure in mucopolysaccharidoses.
    Corte AD; de Souza CFM; Anés M; Maeda FK; Lokossou A; Vedolin LM; Longo MG; Ferreira MM; Perrone SGP; Balédent O; Giugliani R
    Fluids Barriers CNS; 2017 Sep; 14(1):23. PubMed ID: 28918752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging findings of the posterior fossa in 47 patients with mucopolysaccharidoses: A cross-sectional analysis.
    Reichert R; Pérez JA; Dalla-Corte A; Pinto E Vairo F; de Souza CFM; Giugliani R; Isolan GR; Stefani MA
    JIMD Rep; 2021 Jul; 60(1):32-41. PubMed ID: 34258139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroimaging findings in patient series with mucopolysaccharidosis.
    Calleja Gero ML; González Gutiérrez-Solana L; López Marín L; López Pino MA; Fournier Del Castillo C; Duat Rodríguez A
    Neurologia; 2012 Sep; 27(7):407-13. PubMed ID: 22178048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain MRI in mucopolysaccharidosis: effect of aging and correlation with biochemical findings.
    Vedolin L; Schwartz IV; Komlos M; Schuch A; Azevedo AC; Vieira T; Maeda FK; Marques da Silva AM; Giugliani R
    Neurology; 2007 Aug; 69(9):917-24. PubMed ID: 17724296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrocerebellum: significance and pathogenic considerations.
    Poretti A; Mall V; Smitka M; Grunt S; Risen S; Toelle SP; Benson JE; Yoshida S; Jung NH; Tinschert S; Neuhann TM; Rauch A; Steinlin M; Meoded A; Huisman TA; Boltshauser E
    Cerebellum; 2012 Dec; 11(4):1026-36. PubMed ID: 22528964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type II.
    Yund B; Rudser K; Ahmed A; Kovac V; Nestrasil I; Raiman J; Mamak E; Harmatz P; Steiner R; Lau H; Vekaria P; Wozniak JR; Lim KO; Delaney K; Whitley C; Shapiro EG
    Mol Genet Metab; 2015 Feb; 114(2):170-7. PubMed ID: 25541100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroimaging features in mucopolysaccharidosis: their correlation with mental retardation].
    Sá G; Teixeira JF; Cruz R; Barbot C; Martins E
    Rev Neurol; 2006 Dec 16-31; 43(12):760-2. PubMed ID: 17160929
    [No Abstract]   [Full Text] [Related]  

  • 11. Mucopolysaccharidosis type V. (Scheie syndrome). A postmortem study by multidisciplinary techniques with emphasis on the brain.
    Dekaban AS; Constantopoulos G; Herman MM; Steusing JK
    Arch Pathol Lab Med; 1976 May; 100(5):237-45. PubMed ID: 817693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral magnetic resonance findings during enzyme replacement therapy in mucopolysaccharidosis.
    Matsubara Y; Miyazaki O; Kosuga M; Okuyama T; Nosaka S
    Pediatr Radiol; 2017 Nov; 47(12):1659-1669. PubMed ID: 28733853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter alteration and cerebellar atrophy are hallmarks of brain MRI in alpha-mannosidosis.
    Majovska J; Nestrasil I; Paulson A; Nascene D; Jurickova K; Hlavata A; Lund T; Orchard PJ; Vaneckova M; Zeman J; Magner M; Dusek P
    Mol Genet Metab; 2021 Mar; 132(3):189-197. PubMed ID: 33317989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan.
    Tanaka A; Okuyama T; Suzuki Y; Sakai N; Takakura H; Sawada T; Tanaka T; Otomo T; Ohashi T; Ishige-Wada M; Yabe H; Ohura T; Suzuki N; Kato K; Adachi S; Kobayashi R; Mugishima H; Kato S
    Mol Genet Metab; 2012 Nov; 107(3):513-20. PubMed ID: 23022072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal dendritic swellings in Purkinje cells in mucopolysaccharidoses types I, II and III. A Golgi and ultrastructural study.
    Ferrer I; Cusí V; Pineda M; Galofré E; Vila J
    Neuropathol Appl Neurobiol; 1988; 14(4):315-23. PubMed ID: 3146708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone marrow transplantation.
    Seto T; Kono K; Morimoto K; Inoue Y; Shintaku H; Hattori H; Matsuoka O; Yamano T; Tanaka A
    Ann Neurol; 2001 Jul; 50(1):79-92. PubMed ID: 11456314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of magnetic resonance imaging abnormalities in symptomatic patients with Krabbe disease correspond to phenotype.
    Abdelhalim AN; Alberico RA; Barczykowski AL; Duffner PK
    Pediatr Neurol; 2014 Feb; 50(2):127-34. PubMed ID: 24262341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mucopolysaccharidoses: characterization by cranial MR imaging.
    Lee C; Dineen TE; Brack M; Kirsch JE; Runge VM
    AJNR Am J Neuroradiol; 1993; 14(6):1285-92. PubMed ID: 8279321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infratentorial gray matter atrophy and excess in primary craniocervical dystonia.
    Piccinin CC; Santos MC; Piovesana LG; Campos LS; Guimarães RP; Campos BM; Torres FR; França MC; Amato-Filho AC; Lopes-Cendes I; Cendes F; D'Abreu A
    Parkinsonism Relat Disord; 2014 Feb; 20(2):198-203. PubMed ID: 24262871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI in children with mental retardation.
    Soto-Ares G; Joyes B; Lemaître MP; Vallée L; Pruvo JP
    Pediatr Radiol; 2003 May; 33(5):334-45. PubMed ID: 12695867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.